Gene · 2101
Papers2,737
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,737
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways. | Molecules | 2022 | 36557997 | PubTator, text mining | PubMed |
| No Mitochondrial Related Transcriptional Changes in Human Skeletal Muscle after Local Heat Application. | Int J Environ Res Public Health | 2022 | 36554930 | PubTator, text mining | PubMed |
| Contribution of Non-Coding RNAs to Anticancer Effects of Dietary Polyphenols: Chlorogenic Acid, Curcumin, Epigallocatechin-3-Gallate, Genistein, Quercetin and Resveratrol. | Antioxidants (Basel) | 2022 | 36552560 | PubTator, text mining | PubMed |
| Exercise-Boosted Mitochondrial Remodeling in Parkinson's Disease. | Biomedicines | 2022 | 36551984 | PubTator, text mining | PubMed |
| Lipedema: Insights into Morphology, Pathophysiology, and Challenges. | Biomedicines | 2022 | 36551837 | PubTator, text mining | PubMed |
| Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers. | Biomolecules | 2022 | 36551308 | PubTator, text mining | PubMed |
| Utilizing MALDI-TOF MS and LC-MS/MS to access serum peptidome-based biomarkers in canine oral tumors. | Sci Rep | 2022 | 36517562 | PubTator, text mining | PubMed |
| Advances in Molecular Pathology of Obstructive Sleep Apnea. | Molecules | 2022 | 36500515 | PubTator, text mining | PubMed |
| Targeting Mitochondrial Dynamics Proteins for the Development of Therapies for Cardiovascular Diseases. | Int J Mol Sci | 2022 | 36499064 | PubTator, text mining | PubMed |
| Gene variants in eating disorders. Focus on anorexia nervosa, bulimia nervosa, and binge-eating disorder. | J Prev Med Hyg | 2022 | 36479493 | PubTator, text mining | PubMed |
| Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects. | Onco Targets Ther | 2022 | 36474507 | PubTator, text mining | PubMed |
| Quantitative Analysis and Optimization of Site-Specific Protein Bioconjugation in Mammalian Cells. | Bioconjug Chem | 2022 | 36459098 | PubTator, text mining | PubMed |
| Risk stratification system and visualized dynamic nomogram constructed for predicting diagnosis and prognosis in rare male breast cancer patients with bone metastases. | Front Endocrinol (Lausanne) | 2022 | 36440188 | PubTator, text mining | PubMed |
| AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis. | Nat Commun | 2022 | 36433955 | PubTator, text mining | PubMed |
| Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs. | Pharmaceutics | 2022 | 36432713 | PubTator, text mining | PubMed |
| Association of Irisin/FNDC5 with ERRα and PGC-1α Expression in NSCLC. | Int J Mol Sci | 2022 | 36430689 | PubTator, text mining | PubMed |
| Transcriptional upregulation of MAPK15 by NF-κB signaling boosts the efficacy of combination therapy with cisplatin and TNF-α. | iScience | 2022 | 36425765 | PubTator, text mining | PubMed |
| Transposable Elements Continuously Remodel the Regulatory Landscape, Transcriptome, and Function of Decidual Stromal Cells. | Genome Biol Evol | 2022 | 36423206 | PubTator, text mining | PubMed |
| RIP140-Mediated NF-κB Inflammatory Pathway Promotes Metabolic Dysregulation in Retinal Pigment Epithelium Cells. | Curr Issues Mol Biol | 2022 | 36421677 | PubTator, text mining | PubMed |
| PROTACs in gastrointestinal cancers. | Mol Ther Oncolytics | 2022 | 36420306 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2101/papers?page=25